Effectiveness of Immune Checkpoint Inhibition vs Chemotherapy in Combination With Radiation Therapy Among Patients With Non–Small Cell Lung Cancer and Brain Metastasis Undergoing Neurosurgical Resection

IMPORTANCE: Patients with brain metastases from non–small cell lung cancer (NSCLC) have regularly been excluded from prospective clinical trials that include therapy with immune checkpoint inhibitors (ICIs). Clinical data demonstrating benefit with ICIs, specifically following neurosurgical brain me...

Descripción completa

Detalles Bibliográficos
Autores principales: Wasilewski, David, Radke, Josefine, Xu, Ran, Raspe, Matthias, Trelinska-Finger, Anna, Rosenstock, Tizian, Poeser, Paul, Schumann, Elisa, Lindner, Judith, Heppner, Frank, Kaul, David, Suttorp, Norbert, Vajkoczy, Peter, Frost, Nikolaj, Onken, Julia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9055459/
https://www.ncbi.nlm.nih.gov/pubmed/35486401
http://dx.doi.org/10.1001/jamanetworkopen.2022.9553

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9055459/
https://www.ncbi.nlm.nih.gov/pubmed/35486401
http://dx.doi.org/10.1001/jamanetworkopen.2022.9553

Ejemplares similares